News

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...
As the Trump administration cuts thousands of federal jobs, some fired workers worry about health agencies' ability to ...
During a speech at the FDA, the HHS secretary accused staff of becoming "sock puppets" of the industry they regulate. Last ...
Much like Clotiaux’s company, manufacturing is bounding back in Lafayette Parish and Acadiana, Bureau of Labor Statistics ...
From antibiotics and blood-pressure medications to essential cancer treatments, almost all generic drugs consumed in the U.S. are manufactured overseas - primarily in China and India. This dependency ...
Asian stocks rose on Monday as trade war fears were tempered by Donald Trump’s announcement of tariff exemptions for ...
As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.
Capping more than two years of stock-gyrating drama, Pfizer said it would stop development of danuglipron, its experimental oral GLP-1 medicine to treat obesity, focusing its efforts on another ...